{
  "ticker": "LYEL",
  "company_name": "Lyell Immunopharma, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05826535",
      "title": "Study of LYL314 in Aggressive Large B-Cell Lymphoma",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Large B-cell Lymphoma",
      "start_date": "2023-05-09",
      "completion_date": "2031-06-30",
      "enrollment": 0,
      "sponsor": "Lyell Immunopharma, Inc."
    },
    {
      "nct_id": "NCT05274451",
      "title": "A Study to Investigate LYL797 in Adults With Solid Tumors",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Non-small Cell Lung Cancer, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-Small Cell Carcinoma of Lung, TNM Stage 4, Advanced Breast Cancer, Advanced Lung Carcinoma, NSCLC, NSCLC, Recurrent, NSCLC Stage IV, Relapsed Cancer, Relapse/Recurrence, Recurrent Breast Cancer, Recurrent NSCLC, Platinum-resistant Ovarian Cancer, Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer, Endometrial Cancer, Endometrioid Tumor, High Grade Serous Carcinoma, Ovarian Epithelial Cancer",
      "start_date": "2022-03-29",
      "completion_date": "2024-11-27",
      "enrollment": 0,
      "sponsor": "Lyell Immunopharma, Inc."
    },
    {
      "nct_id": "NCT05573035",
      "title": "A Study to Investigate LYL845 in Adults With Solid Tumors",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Melanoma, Non-small Cell Lung Cancer, Colorectal Cancer",
      "start_date": "2022-12-19",
      "completion_date": "2025-01-09",
      "enrollment": 0,
      "sponsor": "Lyell Immunopharma, Inc."
    },
    {
      "nct_id": "NCT05891197",
      "title": "A Biomarker Screening Protocol for Participants With Solid Tumors",
      "status": "TERMINATED",
      "phase": "",
      "condition": "Triple Negative Breast Cancer, Non-small Cell Lung Cancer, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-Small Cell Carcinoma of Lung, TNM Stage 4, Advanced Breast Cancer, Advanced Lung Carcinoma, NSCLC, NSCLC, Recurrent, NSCLC Stage IV, Relapsed Cancer, Relapse/Recurrence, Recurrent Breast Cancer, Recurrent NSCLC, Platinum-resistant Ovarian Cancer, Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer, Endometrial Cancer, Endometrioid Tumor, High Grade Serous Carcinoma, Ovarian Epithelial Cancer",
      "start_date": "2023-05-19",
      "completion_date": "2025-02-05",
      "enrollment": 0,
      "sponsor": "Lyell Immunopharma, Inc."
    },
    {
      "nct_id": "NCT06153095",
      "title": "A Study of IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)",
      "status": "WITHDRAWN",
      "phase": "PHASE1, PHASE2",
      "condition": "Systemic Lupus Erythematosus, Lupus Nephritis",
      "start_date": "2024-02-15",
      "completion_date": "2025-01-09",
      "enrollment": 0,
      "sponsor": "Lyell Immunopharma, Inc."
    },
    {
      "nct_id": "NCT07188558",
      "title": "A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Large B-cell Lymphoma, Lymphoma, B-Cell, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Non-Hodgkin Lymphoma Refractory/ Relapsed, Diffuse Large B Cell Lymphoma (DLBCL), Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed",
      "start_date": "2026-01",
      "completion_date": "2032-01",
      "enrollment": 0,
      "sponsor": "Lyell Immunopharma, Inc."
    }
  ],
  "summary": {
    "total_trials": 6,
    "by_phase": {
      "PHASE1, PHASE2": 2,
      "PHASE1": 2,
      "": 1,
      "PHASE3": 1
    },
    "by_status": {
      "RECRUITING": 2,
      "TERMINATED": 3,
      "WITHDRAWN": 1
    },
    "active_trials": 2,
    "completed_trials": 0,
    "conditions": [
      "Large B-cell Lymphoma, Lymphoma, B-Cell, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Non-Hodgkin Lymphoma Refractory/ Relapsed, Diffuse Large B Cell Lymphoma (DLBCL), Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed",
      "Melanoma, Non-small Cell Lung Cancer, Colorectal Cancer",
      "Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Large B-cell Lymphoma",
      "Systemic Lupus Erythematosus, Lupus Nephritis",
      "Triple Negative Breast Cancer, Non-small Cell Lung Cancer, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-Small Cell Carcinoma of Lung, TNM Stage 4, Advanced Breast Cancer, Advanced Lung Carcinoma, NSCLC, NSCLC, Recurrent, NSCLC Stage IV, Relapsed Cancer, Relapse/Recurrence, Recurrent Breast Cancer, Recurrent NSCLC, Platinum-resistant Ovarian Cancer, Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer, Endometrial Cancer, Endometrioid Tumor, High Grade Serous Carcinoma, Ovarian Epithelial Cancer",
      "Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Non-small Cell Lung Cancer, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-Small Cell Carcinoma of Lung, TNM Stage 4, Advanced Breast Cancer, Advanced Lung Carcinoma, NSCLC, NSCLC, Recurrent, NSCLC Stage IV, Relapsed Cancer, Relapse/Recurrence, Recurrent Breast Cancer, Recurrent NSCLC, Platinum-resistant Ovarian Cancer, Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer, Endometrial Cancer, Endometrioid Tumor, High Grade Serous Carcinoma, Ovarian Epithelial Cancer"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:19:47.703914",
    "search_query": "Lyell Immunopharma, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Lyell+Immunopharma,+Inc."
  }
}